文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

Alda-1治疗减轻猪心脏骤停复苏后肺损伤

ALDA-1 TREATMENT ALLEVIATES LUNG INJURY AFTER CARDIAC ARREST AND RESUSCITATION IN SWINE.
PubMed 文献 · Shock · 2022-09-27
一句话结论猪心脏骤停/复苏模型中,复苏后5分钟静脉注射Alda-1 0.88 mg/kg可减轻肺损伤,机制可能与抑制细胞凋亡和铁死亡有关。

研究将24头猪随机分为假手术组(n=6)、心脏骤停/心肺复苏组(n=10)和心脏骤停/心肺复苏+Alda-1组(n=8),以8分钟电诱导未处理心脏骤停后8分钟人工心肺复苏建立模型,复苏后5分钟静脉注射Alda-1 0.88 mg/kg。复苏后4小时内定期评估血管外肺水指数、肺血管通透性指数和氧合指数,24小时检测肺ALDH2活性、损伤评分、凋亡和铁死亡。结果显示Alda-1组上述肺损伤指标较心脏骤停/心肺复苏组显著改善,肺ALDH2活性显著高于心脏骤停/心肺复苏组,损伤评分、凋亡和铁死亡显著降低。作者认为Alda-1可能为心脏骤停/心肺复苏后肺保护提供新的治疗靶点和可行药物。

要点

  • 猪心脏骤停/心肺复苏模型中,复苏后5分钟静脉注射Alda-1 0.88 mg/kg,可显著改善复苏后4小时内的血管外肺水指数、肺血管通透性指数和氧合指数。
  • 心脏骤停/心肺复苏后肺ALDH2活性较假手术组显著降低,Alda-1治疗组肺ALDH2活性显著高于心脏骤停/心肺复苏组。
  • Alda-1治疗组肺损伤评分、细胞凋亡和铁死亡较心脏骤停/心肺复苏组显著降低。
  • 心脏骤停/心肺复苏组10头中5头、Alda-1组8头中6头恢复自主循环。
  • 作者认为Alda-1可能通过抑制细胞凋亡和铁死亡减轻复苏后肺损伤,可能为肺保护提供新靶点和可行药物。

适用人群与场景

  • 猪心脏骤停/心肺复苏模型:8分钟电诱导未处理心脏骤停后8分钟人工心肺复苏。
  • 共24头猪随机分为假手术组(n=6)、心脏骤停/心肺复苏组(n=10)、心脏骤停/心肺复苏+Alda-1组(n=8)。

处置流程与药物剂量

  • Alda-1 0.88 mg/kg,静脉注射,于心脏骤停/心肺复苏后5分钟给药(猪模型)。
  • 复苏后4小时内定期评估血管外肺水指数、肺血管通透性指数和氧合指数;24小时检测肺ALDH2活性、损伤评分、凋亡和铁死亡。

研究设计与关键结果

  • 研究类型:动物实验(猪心脏骤停/心肺复苏模型),24头猪随机分为假手术组(n=6)、心脏骤停/心肺复苏组(n=10)、心脏骤停/心肺复苏+Alda-1组(n=8)。
  • 复苏后恢复自主循环:心脏骤停/心肺复苏组10头中5头,心脏骤停/心肺复苏+Alda-1组8头中6头。
  • 与假手术组相比,心脏骤停/心肺复苏组和心脏骤停/心肺复苏+Alda-1组血管外肺水指数和肺血管通透性指数显著升高、氧合指数显著降低;Alda-1治疗组上述指标逐渐改善且显著优于心脏骤停/心肺复苏组。
  • 肺ALDH2活性:心脏骤停/心肺复苏组较假手术组显著降低;心脏骤停/心肺复苏+Alda-1组显著高于心脏骤停/心肺复苏组。
  • 肺损伤评分、凋亡和铁死亡:心脏骤停/心肺复苏组和心脏骤停/心肺复苏+Alda-1组较假手术组显著升高;Alda-1治疗组较心脏骤停/心肺复苏组显著降低。

证据类型、等级与局限

  • 证据类型:动物实验(猪心脏骤停/心肺复苏模型)。
  • 作者结论:Alda-1治疗可减轻猪心脏骤停/心肺复苏后肺损伤,保护作用可能与抑制细胞凋亡和铁死亡有关;可能提供新的治疗靶点和可行药物。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Introduction: Alda-1, an aldehyde dehydrogenase 2 (ALDH2) activator, has been shown to protect the lung against a variety of diseases including regional ischemia-reperfusion injury, severe hemorrhagic shock, hyperoxia, and so on. The present study was designed to investigate the effectiveness of Alda-1 treatment in alleviating lung injury after cardiac arrest (CA) and cardiopulmonary resuscitation (CPR) in swine. Methods: A total of 24 swine were randomized into three groups: sham (n = 6), CA/CPR (n = 10), and CA/CPR + Alda-1 (n = 8). The swine model was established by 8 min of electrically induced and untreated CA, and then 8 min of manual CPR. A dose of 0.88 mg/kg of Alda-1 was intravenously injected at 5 min after CA/CPR. After CA/CPR, extravascular lung water index (ELWI), pulmonary vascular permeability index (PVPI), and oxygenation index (OI) were regularly evaluated for 4 h. At 24 h after resuscitation, lung ALDH2 activity was detected, and its injury score, apoptosis, and ferroptosis were measured. Results: After experiencing the same procedure of CA and CPR, five swine in the CA/CPR group and six swine in the CA/CPR + Alda-1 group restored spontaneous circulation. Subsequently, significantly increased ELWI and PVPI, and markedly decreased OI were observed in these two groups compared with the sham group. However, all of them were gradually improved and significantly better in the swine treated with the Alda-1 compared with the CA/CPR group. Tissue analysis indicated that lung ALDH2 activity was significantly decreased in those swine experiencing the CA/CPR procedure compared with the sham group; nevertheless, its activity was significantly greater in the CA/CPR + Alda-1 group than in the CA/CPR group. In addition, lung injury score, and its apoptosis and ferroptosis were significantly increased in the CA/CPR and CA/CPR + Alda-1 groups compared with the sham group. Likewise, Alda-1 treatment significantly decreased these pathological damages in lung tissue when compared with the CA/CPR group. Conclusions: Alda-1 treatment was effective to alleviate lung injury after CA/CPR in a swine model, in which the protective role was possibly related to the inhibition of cell apoptosis and ferroptosis. It might provide a novel therapeutic target and a feasible therapeutic drug for lung protection after CA/CPR.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wu H, Xu S, Diao M, et al. ALDA-1 TREATMENT ALLEVIATES LUNG INJURY AFTER CARDIAC ARREST AND RESUSCITATION IN SWINE. Shock. 2022. PMID: 36156537. doi:10.1097/SHK.0000000000002003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。